Mobile

A randomised, parallel-group, open-labelled, multinational trial comparing the efficacy and safety of insulin detemir (Levemir®) versus human insulin (NPH insulin), used in combination with insulin as...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004861-33

A randomised, parallel-group, open-labelled, multinational trial comparing the efficacy and safety of insulin detemir (Levemir®) versus human insulin (NPH insulin), used in combination with insulin aspart as bolus insulin, in the treatment of pregnant women with type 1 diabetes Trial Phase: 3b

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the glycaemic control measured as HbA1c obtained by using either insulin detemir or NPH insulin at gestational week (GW) = 36 (P4).

Critère d'inclusion

  • Type 1 Diabetes

Liens